Juliet Labadorf
Senior Director, Investor Relations & Corporate Development
Bio:
Senior Director, Investor Relations & Corporate Development
Juliet joined Sionna Therapeutics in 2021 and leads investor engagement, corporate development initiatives, and communications. Before transitioning into her current role, she established the company’s financial planning and analysis function, drove resource allocation and long-range planning, and supported multiple financings, including its IPO.
She brings more than 12 years of experience across finance and strategy. Prior to Sionna, Juliet worked at Cullinan Oncology, supporting the company through its early stage as a public company, and at BlueRock Therapeutics, where she built FP&A capabilities and supported its acquisition by Bayer. She began her career in finance at Deloitte, HBO, and Squarespace before moving into biotechnology.
Juliet earned her B.S. in Accounting from Lehigh University and received her M.S. in Accounting from Yeshiva University.